Sartorius Stedim Biotech (Sartorius Stedim Biotech) Beginning Cash Position : $108 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech Beginning Cash Position?

Sartorius Stedim Biotech's Beginning Cash Position for the quarter that ended in Dec. 2023 was $108 Mil.

Sartorius Stedim Biotech's quarterly Beginning Cash Position increased from Jun. 2023 ($102 Mil) to Sep. 2023 ($117 Mil) but then declined from Sep. 2023 ($117 Mil) to Dec. 2023 ($108 Mil).

Sartorius Stedim Biotech's annual Beginning Cash Position increased from Dec. 2021 ($68 Mil) to Dec. 2022 ($237 Mil) but then declined from Dec. 2022 ($237 Mil) to Dec. 2023 ($117 Mil).

Sartorius Stedim Biotech Beginning Cash Position Historical Data

The historical data trend for Sartorius Stedim Biotech's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Beginning Cash Position Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

26.64

34.27

67.57

236.86

116.79

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															154.13	114.56	101.95	117.40	108.29

Sartorius Stedim Biotech Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Sartorius Stedim Biotech Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

SRTOY:USA DIM:Mexico DIMp:UK 0RG8:UK DIM:France 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.